Patent quality matters to industrial automation companies because patents can shape how technology is developed, licensed, challenged and commercialized. For engineers, system integrators and operations leaders, the practical issue is not simply whether patents should be strong, but how to protect genuine innovation while addressing claims that may cover old or obvious ideas. In 2019 congressional testimony, Cisco executive Dan Lang argued that a balanced system depends in part on post-grant patent review and a measured approach to injunctions.
The testimony addressed the proposed STRONGER Patents Act of 2019 and defended mechanisms introduced by the America Invents Act (AIA). Its arguments offer a useful framework for considering how patent rules can affect technology businesses across sectors, including companies that develop and deploy complex products.
Why patent quality matters to technology businesses
A patent grants a time-limited right, but the testimony emphasized that the purpose of patent law is to promote progress in science and useful arts—not simply to create private value for patent owners. That distinction matters in industries where products combine many technologies and where research, engineering and commercialization require substantial investment.
When a patent claim is valid and protects a meaningful contribution, it can support the inventor’s ability to benefit from that work. But a low-quality patent can also lead to disputes over technology that was already known or that contributes only a small part of a larger product. The testimony warned that enforcing such claims can divert resources from product development and place pressure on companies to settle, even when they believe the allegation is unfounded.
For automation businesses, this is a risk-management issue as well as a legal one. Patent disputes can affect product planning, licensing decisions and the cost of bringing technology to market. The testimony’s broader point is that patent rules should account for both the interests of inventors and the consequences of enforcement for companies that build and use technology.
Inter partes review as a route to reassessing patents
The AIA created inter partes review (IPR) and post-grant review (PGR), allowing certain challenges to issued patents to be heard by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). The process gives parties an avenue to present evidence that a patent should not have been granted, including relevant earlier patents, for review by patent specialists.
Lang described IPR as a faster and less expensive alternative to resolving patent validity solely through district court litigation. In the Cisco-Uniloc dispute recounted in the testimony, Cisco challenged patents concerning a feature for initiating a conference call from an instant messaging conversation. Cisco said the PTAB invalidated the asserted patents after review; the decisions were on appeal at the time of the testimony. The example illustrates how post-grant review can become part of a company’s response when it believes a patent is invalid.
The concern with limiting repeat challenges
The testimony opposed provisions in the proposed bill that, in its view, would sharply restrict the ability to bring IPR petitions. One concern was a “one and done” approach: if one challenge had already been instituted, later petitioners could be barred from bringing their own. Different companies may have different products, evidence or prior art to present, the testimony argued. It also noted that an earlier petitioner might settle before a final decision, potentially leaving other accused parties without their own opportunity to challenge the patent.
Lang also objected to raising the evidentiary standard for IPR challenges to clear and convincing evidence, arguing that the PTAB is reassessing a patent rather than a court deferring to the patent office’s original decision. These were arguments against the proposed legislation, not a claim that every challenge is justified. The testimony acknowledged that duplicative or serial petitions can be problematic and supported allowing the USPTO to manage them using experience and discretion.
Injunctions and the leverage of a patent claim
A second major issue was the proposed treatment of injunctions. Following the Supreme Court’s 2006 eBay decision, injunctions in patent cases are subject to an equitable test rather than being automatic whenever infringement is found. The testimony supported retaining that approach, under which an injunction remains available when money damages would not adequately address the patent owner’s harm.
Lang warned that making injunctions presumptively available could give a patent owner substantial negotiating leverage, particularly when the patented feature is only a small component of a larger product. The risk of interrupted sales or redesign, he argued, could push a company toward a settlement that exceeds the reasonable value of the patented contribution. For products incorporating numerous technologies, this concern highlights why remedies and damages should be connected to the specific invention and the harm established.
Improving the system without removing flexibility
The testimony did not argue that the patent system was beyond improvement. It supported efforts to strengthen patent examination and improve the quality of issued patents, including better search capabilities and adequate resources for the USPTO. It also urged caution about writing detailed procedural rules into statute when the agency could adjust its practices based on experience.
Among the changes Lang advocated were clarifying how the one-year deadline for an IPR petition applies to claims asserted in a complaint, and allowing certain patent-scope and disclosure challenges under section 112 to be addressed in court and through IPR. These proposals reflect a central theme: improving patent quality requires attention both to the examination process and to the mechanisms available when questions arise after a patent is issued.
Practical implications for industrial automation
Industrial companies can take several lessons from this debate:
- Assess the scope of a claim. A dispute may concern one feature within a broader product, so the contribution of that feature should not be confused with the value of the entire system.
- Consider review options early. The testimony highlights that deadlines and procedural limits can affect whether a company may challenge a patent through IPR.
- Account for remedy risk. Injunction exposure can influence negotiations even before a final decision, making the available remedy part of broader product and legal risk planning.
- Support reliable patent examination. Better patent quality can benefit both innovators seeking dependable protection and businesses seeking clarity about the technologies they can use.
Conclusion
The testimony’s core message is that stronger patent rights do not automatically produce more innovation. For industrial automation companies, a balanced system means protecting valid inventions while maintaining credible ways to challenge questionable patents and applying injunctions in light of the harm involved. Patent quality, effective review and proportionate remedies are therefore not abstract policy questions: they can shape the costs, risks and choices involved in developing and deploying technology.